Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.66B 1.13B 989M 914M 844M 1.59B 109B 1.62B 10.9B 4.28B 53.21B 4.25B 4.16B 183B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 5.17B 763M 667M 617M 570M 1.07B 73.32B 1.09B 7.35B 2.89B 35.9B 2.87B 2.8B 124B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+1.31%
1 week+5.64%
Current month+17.04%
1 month+5.47%
3 months+7.36%
6 months-12.12%
Current year-11.17%
1 week 12.2
Extreme 12.2
13.3
1 month 11.04
Extreme 11.04
13.3
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
17.17
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 06/01/2019
Director of Finance/CFO 49 05/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 25/03/2014
Director/Board Member 64 25/09/2017
Director/Board Member 44 25/09/2017
Date Insider Type Main position Quantity % Market Cap.
16/07/24Buy 500 0.0001%
21/01/20Sell

Director

246,300 0.0462%
31/12/19Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+5.64%-18.05%-40.95% 1.13B
+0.60%+2.88%-10.61%-7.81% 13.19B
+0.90%+7.19%-30.61%-52.51% 5.01B
+0.70%+4.58%-1.29%-4.12% 4.62B
+4.13%+12.09%+14.64%-31.40% 4.23B
+2.50%-0.35%+19.00%-1.67% 3.89B
+2.60%+9.35%-3.99%-8.08% 3.44B
+1.46%+3.99%-8.01%+5.57% 3.22B
+1.47%+4.82%-7.89%-21.19% 2.47B
+0.18%+5.83%-0.83%+52.76% 1.89B
Average +1.58%+4.22%-4.76%-10.94% 4.31B
Weighted average by Cap. +1.44%+4.12%-5.67%-12.38%

Financials

2024 2025
Net sales 3.38B 499M 436M 403M 372M 701M 47.89B 714M 4.8B 1.88B 23.45B 1.87B 1.83B 80.75B 2.32B 342M 299M 276M 255M 481M 32.87B 490M 3.3B 1.29B 16.1B 1.29B 1.26B 55.43B
Net income 492M 72.65M 63.49M 58.69M 54.22M 102M 6.98B 104M 700M 275M 3.42B 273M 267M 11.77B -258M -38.07M -33.27M -30.75M -28.41M -53.51M -3.66B -54.47M -367M -144M -1.79B -143M -140M -6.17B
Net Debt -2.29B -338M -295M -273M -252M -475M -32.47B -484M -3.26B -1.28B -15.9B -1.27B -1.24B -54.75B -2.49B -368M -322M -297M -275M -517M -35.34B -527M -3.54B -1.39B -17.31B -1.38B -1.35B -59.59B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
14/07/26 CN¥13.12 +1.31% 13,326,373
13/07/26 CN¥12.95 +3.35% 12,057,807
10/07/26 CN¥12.53 +0.97% 5,586,867
09/07/26 CN¥12.41 -0.96% 5,959,081
08/07/26 CN¥12.53 +0.89% 5,369,673

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock